New study aims to sharpen heart disease detection
NCT ID NCT03674255
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This large UK study (EVAREST) aims to improve how doctors interpret stress echocardiograms for diagnosing coronary artery disease. Researchers will collect blood samples and analyze echocardiogram images from up to 23,000 patients to find new biomarkers that make diagnosis more accurate and consistent. The goal is to reduce uncertainty and the need for additional invasive tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate and consistent diagnosis of heart disease using stress echocardiograms, reducing the need for invasive tests.
- What could go wrong
- This is an observational study, not a treatment trial. It may not change current practice if the biomarkers do not prove reliable enough in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGINA PECTORIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Step by step: a coaching program aims to keep heart patients moving after rehab
- Heart bypass upgrade: which Artery-Harvesting technique works best?
- Can a noble gas protect the heart during bypass surgery?
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack